Back

Inhibitory mechanisms of very low dose rivaroxaban in non-ST-elevation myocardial infarction

27 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Best Posters 5 - Best Posters in acute coronary syndrome, new insights Thrombosis, Platelets, and Coagulation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Oliver Borst

University Hospital of Tuebingen, Tuebingen (Germany)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Professor D. Sim (Gwangju, KR)
Abstract
Presentation thumbnail
Doctor N. Cosentino (Milan, IT)
Abstract Slides
Presentation thumbnail
Doctor W. Sumaya (Halifax, CA)
Abstract Slides

Access the full session

Session thumbnail
Best Posters 5 - Best Posters in acute coronary syndrome, new insights

The Event

Event poster

ESC Congress 2018

27 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Session
State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?
14 March 2025
thumbnail
Congress Presentation
Efficacy and safety of low-dose rivaroxaban on top of aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial
30 August 2020
thumbnail
Congress Presentation
Plasma levels of direct oral anticoagulants in non-valvular atrial fibrillation patients at the time of acute cardioembolic or bleeding events
28 August 2023
thumbnail
ESC Journals
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry
19 October 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources